February 04, 2025

FDA Approves Clinical Trials for Genetically Modified Pig Kidney Transplants

FDA-cleared clinical trials will assess the safety, immunogenicity, and viability of genetically modified pig kidney transplants in patients with end-stage renal disease.

Conexiant

January 29, 2025

Medication Burden and Injurious Falls Among Patients With COPD

Agents such as benzodiazepines, sedative-hypnotics, antihypertensives, and other psychoactive drugs—often used to treat comorbidities in patients with COPD—may be contributing to an increased risk of falls among this population near the end of life.

Conexiant

January 27, 2025

FDA Approves New Leqembi Dosing Regimen

Leqembi gains FDA approval for updated intravenous dosing schedule for early Alzheimer’s disease.

Conexiant

January 27, 2025

Montelukast Safety in Neuropsychiatric Risks: Study in Children

A large cohort study finds no link between montelukast use and neuropsychiatric adverse events in children, supporting its safety for asthma and allergic rhinitis management.

Conexiant

January 24, 2025

Addressing Sexual Health Misconceptions During Pregnancy

Findings detailed the high prevalence of sexual dysfunction during pregnancy, beliefs impacting sexual health, and the importance of integrating proactive discussions into prenatal care.

Conexiant

January 23, 2025

Sjögren’s Disease: Impact on Sexual Health

Explore the link between Sjögren’s disease, sexual dysfunction, and depression through an in-depth analysis of patient-reported outcomes.

Conexiant

January 16, 2025

EHR Systems Boost Depression Screening in cSLE

Discover how automated EHR-driven systems significantly improved depression screening rates for youth with childhood-onset systemic lupus erythematosus in a pediatric rheumatology clinic.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Updated TMS Guidelines for Depression Treatment

Explore the latest transcranial magnetic stimulation guidelines for depression, including updated protocols, safety data, and tailored recommendations for clinicians.

Conexiant